logo-loader
Laneway Resources Ltd

Laneway Resources raises funds for gold drilling in Queensland

au_qld_map_350_5440648c22e41.jpg

Laneway Resources (ASX:LNY) has entered into commitments for a capital raising of up to $600,000 and a Drilling Funding Agreement for up to 350,000 million worth of drilling and associated activities.

The capital raising consists of the issue of up to 200 million ordinary shares with an issue price of $0.003 per share which represents a 20% premium to Laneway’s 10 day VWAP.

Drilling activities worth up to $350,000 to be funded by the issue of up to 100 million ordinary shares at an issue price of $0.0035.

Funds will be primarily directed towards a 5,000 metres drilling program at Agate Creek gold project in Queensland.

The company will also continue the work required to apply for a Mining Lease over part of the project, which will enable a metallurgical sample of up to 40,000 tonnes to investigate process route and gold recovery refinements.

This follows the 5,472 tonne metallurgical sample taken from the project earlier this year from which 1,725 ounces of gold were recovered.

The capital raising and drilling funding arrangements will enable Laneway to advance its Agate Creek gold, New Zealand gold and New South Wales coal projects.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Laneway Resources Ltd

Price: $0.01

Market: ASX
Market Cap: $27.9 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Lexagene Develops technology to test for deadly mosquito...

Lexagene (CVE: LXG-OTCQB-LXXGF) Founder and CEO Dr jack Regan joined Steve Darling from Proactive Vancouver on Skype with news the company has used their proprietary technology to develop a detection system for the Eastern Equine Encephalitis or EEE. Regan says that not only can they use the...

45 minutes ago

2 min read